Search Results for 'Tdf-Hiv'

Tdf-Hiv published presentations and documents on DocSlides.

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
by iris
ADVANCE. . Design. Primary endpoint. Proportion ...
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
DTG + 3TC versus DTG + TDF-FTC as Initial ART
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
Switching to TAF from TDF, each with RPV and FTC
Switching to TAF from TDF, each with RPV and FTC
by julia
Study GS-366-1216. Switch from TDF to TAF, each wi...
Switch  from  TDF to TAF
Switch from TDF to TAF
by easyho
GS-US-292-0109 Study. GS-US-311-1089 Study. . De...
Switch de TDF a TAF Estudio GS-US-292-0109
Switch de TDF a TAF Estudio GS-US-292-0109
by calandra-battersby
Estudio GS-US-311-1089 . Estudio GS-US-366-1216 ....
HIV  Update Ardis Moe, M.D.
HIV Update Ardis Moe, M.D.
by nonhurmer
amoe@mednet.ucla.edu. UCLA CARE clinic/NEVHC Van N...
Use of HCV DAAs with HIV Regimens
Use of HCV DAAs with HIV Regimens
by robaut
Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....
HIV Medicine From Guidelines to Practice
HIV Medicine From Guidelines to Practice
by jubilantbikers
Kiat. . Ruxrungtham. Professor of Medicine, . Chu...
Pre-Exposure Prophylaxis ( PrEP )  for HIV Infection Jeffrey D. Klausner, MD, MPH
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH
by kittie-lecroy
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infect...
Treating HIV Infection: HIV/AIDS Treatment
Treating HIV Infection: HIV/AIDS Treatment
by celsa-spraggs
A Dynamic Field. SINGLE Study. Phase 3, Open-Labe...
Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education
Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education
by calandra-battersby
Massachusetts General Hospital. Boston, Massachus...
HIV Medicine From Guidelines to Practice
HIV Medicine From Guidelines to Practice
by cheryl-pisano
Kiat. . Ruxrungtham. Professor of Medicine, . Ch...
Pre-exposure Prophylaxis for HIV Prevention
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
Overview of HIV Epidemiology and Prevention Sciences for ke
Overview of HIV Epidemiology and Prevention Sciences for ke
by alida-meadow
Stefan Baral, MD MPH FRCPC. Center for Public Hea...
Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial
Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial
by keanu817
RADAR Trial. Raltegravir. + Darunavir/r versus TD...
Switch from Efavirenz + ZDV-3TC to Efavirenz + TDF-FTC
Switch from Efavirenz + ZDV-3TC to Efavirenz + TDF-FTC
by ramon803
SWEET Trial . Switch to Efavirenz + TDF-FTC . SWEE...
Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)
Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)
by zane419
Study 105. Atazanavir + [Cobicistat or Ritonavir] ...
Switch to DOR-TDF-3TC vs. Continued Baseline Regimen
Switch to DOR-TDF-3TC vs. Continued Baseline Regimen
by dorothy
DRIVE SHIFT. Switch to Doravirine-TDF-3TC versus C...
Switching to TDF-FTC  from ABC-3TC for Hyperlipidemia
Switching to TDF-FTC from ABC-3TC for Hyperlipidemia
by trinity
ROCKET II. Switching to TDF-FTC from ABC-3TC . for...
EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)
EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)
by tawny-fly
M Harris, . S Guillemi. , K Chan, B Yip. ,. . M ...
NRTI-sparing SPARTAN PROGRESS
NRTI-sparing SPARTAN PROGRESS
by shepard237
RADAR. NEAT001/ANRS 14. 3 . A4001078. VEMAN. MODER...
Optimization of Antiretroviral Therapy
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
Cabotegravir, Long-acting Injectable
Cabotegravir, Long-acting Injectable
by jacey
Last Updated: October 6, 2023. Prepared by:. David...
Eric S.  Daar , MD  Michael S.
Eric S. Daar , MD Michael S.
by ButterflyHeart
Saag. , MD. Antiretroviral Therapy:. A Case-Based ...
Brad  Hare Nothing to Disclose
Brad Hare Nothing to Disclose
by beatrice
Kaiser Permanente San Francisco Medical Center. Sa...
CROI Update: Best of Boston
CROI Update: Best of Boston
by triclin
p. resented by. NCATEC. March . 18, . 2014. David ...
Eric S.  Daar , MD Professor of Medicine
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
Use the Web Browser on Your Mobile Device to Participate in Polling*
Use the Web Browser on Your Mobile Device to Participate in Polling*
by phoebe-click
Go to: pollev.com/CCO2. or scan the QR code below...
What’s Next – and When:
What’s Next – and When:
by sherrill-nordquist
An Update on Injectable . P. revention. Alex R Ri...
ART Initiation:  PrEP  and
ART Initiation: PrEP and
by alida-meadow
Treatment-naïve Patients . Clinical Instructor, ...
Clinical  Management Module
Clinical Management Module
by stefany-barnette
4. . (b) . Risks and Side Effects. Overview. Res...
The Evidence  –  PrEP  Effectiveness
The Evidence – PrEP Effectiveness
by lindy-dunigan
Module . 1(b). The Evidence in Detail. Session Ov...
Michael S.  Saag , MD  Eric S.
Michael S. Saag , MD Eric S.
by pamella-moone
Daar. , MD. Antiretroviral Therapy:. A Case-Based...
Eric S.  Daar , MD Professor of Medicine
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by cheryl-pisano
FLAMINGO. GS-236-0103. ACTG A5257. WAVES . ARIA ....